← Leaderboards
William Robert Taylor
Emory University
$39,404,588
Attributed
$44,023,447
Total exposure
32
Grants
29
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$126,785,244 · 33
By mechanism
UL1$90,161,201 · 9
R01$25,175,989 · 8
T32$6,545,856 · 1
P01$4,647,832 · 3
M01$254,366 · 12
Top collaborators
- Elizabeth O Ofili18 shared
- Bradley George Phillips18 shared
- Andres J Garcia17 shared
- Mark Myron Goodman8 shared
- Niren Murthy8 shared
- David R Archer4 shared
- Henry M Blumberg1 shared
Most similar at Emory University
Same institution · by research overlap
- Bradley George Phillips$290,954
- Paige E Tolbert$4,853,813
- David S Stephens$107,429,191
- Mark Myron Goodman$10,198,938
- Mohammed Kumail Ali$8,364,322
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseResearch PersonnelClinical ResearchResponseAtherosclerosisFundingClinical SciencesTranslational ResearchInflammationCellsBlood VesselsMorbidity - Disease RateInflammatoryInsightProgramsSiteCommunitiesTrainingTissuesIn VitroMacrophageComplexHealthcareInnovation
Grant awards (107)
Georgia Clinical & Translational Science Alliance (Georgia CTSA)$9,325,448
UL1 · FY2025 · TR · contact PI
Georgia Clinical & Translational Science Alliance (Georgia CTSA)$9,325,448
UL1 · FY2024 · TR · contact PI
Georgia Clinical & Translational Science Alliance (Georgia CTSA)$9,325,448
UL1 · FY2023 · TR · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$664,310
R01 · FY2023 · EB · contact PI
Research Training in Academic Cardiology$346,697
T32 · FY2023 · HL · contact PI
Georgia Clinical & Translational Science Alliance (Georgia CTSA)$9,381,948
UL1 · FY2022 · TR · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$667,650
R01 · FY2022 · EB · contact PI
Research Training in Academic Cardiology$645,294
T32 · FY2022 · HL · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$8,523,526
UL1 · FY2021 · TR · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$1,520,907
UL1 · FY2021 · TR · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$667,778
R01 · FY2021 · EB · contact PI
Research Training in Academic Cardiology$613,803
T32 · FY2021 · HL · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$176,893
UL1 · FY2021 · TR · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$8,820,473
UL1 · FY2020 · TR · contact PI
Imaging bacterial infections with 2nd generation maltodextrins$710,274
R01 · FY2020 · EB · contact PI
Research Training in Academic Cardiology$603,992
T32 · FY2020 · HL · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$225,579
UL1 · FY2020 · TR · contact PI
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)$177,500
UL1 · FY2020 · TR · contact PI
Georgia CTSA Research Supplement to Promote Diversity in Health-Related Research (Dunn)$176,798
UL1 · FY2020 · TR · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$131,180
UL1 · FY2020 · TR · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$8,482,560
UL1 · FY2019 · TR · contact PI
Impaired Collateral Vessel Formation in Sickle Cell Disease$605,307
R01 · FY2019 · HL · contact PI
Research Training in Academic Cardiology$572,024
T32 · FY2019 · HL · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$419,700
UL1 · FY2019 · TR · contact PI
Catalase: a pivotal regulator of vascular disease$335,263
P01 · FY2019 · HL · contact PI
Georgia CTSA Research Supplement to Promote Diversity in Health-Related Research (Cobran)$53,104
UL1 · FY2019 · TR · contact PI
Georgia CTSA Research Supplement to Promote Diversity in Health-Related Research (Hernandez)$34,631
UL1 · FY2019 · TR · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$8,131,267
UL1 · FY2018 · TR · contact PI
Impaired Collateral Vessel Formation in Sickle Cell Disease$605,307
R01 · FY2018 · HL · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2018 · EB · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$367,914
UL1 · FY2018 · TR · contact PI
Research Training in Academic Cardiology$353,792
T32 · FY2018 · HL · contact PI
Catalase: a pivotal regulator of vascular disease$335,263
P01 · FY2018 · HL · contact PI
Georgia Clinical & Translational Science Alliance (GaCTSA)$8,161,473
UL1 · FY2017 · TR · contact PI
Core-001$1,745,835
UL1 · FY2017 · TR · contact PI
Core-005$1,286,257
UL1 · FY2017 · TR · contact PI
Core-002$1,077,817
UL1 · FY2017 · TR · contact PI
Core-003$874,796
UL1 · FY2017 · TR · contact PI
Core-006$839,980
UL1 · FY2017 · TR · contact PI
Core-004$751,084
UL1 · FY2017 · TR · contact PI
Impaired Collateral Vessel Formation in Sickle Cell Disease$605,307
R01 · FY2017 · HL · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2017 · EB · contact PI
Research Training in Academic Cardiology$571,581
T32 · FY2017 · HL · contact PI
Core-007$428,413
UL1 · FY2017 · TR · contact PI
Core-008$395,222
UL1 · FY2017 · TR · contact PI
Catalase: a pivotal regulator of vascular disease$335,264
P01 · FY2017 · HL · contact PI
Research Trainng in Academic Cardiology$1,917
T32 · FY2017 · HL · contact PI
Impaired Collateral Vessel Formation in Sickle Cell Disease$605,307
R01 · FY2016 · HL · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$597,089
R01 · FY2016 · EB · contact PI
Research Training in Academic Cardiology$543,847
T32 · FY2016 · HL · contact PI
Catalase: a pivotal regulator of vascular disease$335,263
P01 · FY2016 · HL · contact PI
18F Conjugated Maltodextrins for the Detection of Medical Device Infections$611,089
R01 · FY2015 · EB · contact PI
Research Training in Academic Cardiology$543,501
T32 · FY2015 · HL · contact PI
Catalase: a pivotal regulator of vascular disease$335,263
P01 · FY2015 · HL · contact PI
Research Training in Academic Cardiology$432,727
T32 · FY2014 · HL · contact PI
Role of inflammatory cell RAGE in collateral vessel formation$357,978
P01 · FY2013 · HL · contact PI
Research Training in Academic Cardiology$288,015
T32 · FY2013 · HL · contact PI
Biology, Biomechanics and Atherosclerosis$1,181,207
R01 · FY2012 · HL · contact PI
Research Training in Academic Cardiology$518,684
T32 · FY2012 · HL · contact PI
Role of inflammatory cell RAGE in collateral vessel formation$383,513
P01 · FY2012 · HL · contact PI
Osteopontin and Collateral Vessel Growth$344,471
R01 · FY2012 · HL · contact PI
Biology, Biomechanics and Atherosclerosis$1,187,007
R01 · FY2011 · HL · contact PI
Research Training in Academic Cardiology$509,982
T32 · FY2011 · HL · contact PI
Role of inflammatory cell RAGE in collateral vessel formation$384,760
P01 · FY2011 · HL · contact PI
Hypertension, Hydrogen Peroxide and Vascular Inflammation$348,750
R01 · FY2011 · HL · contact PI
Osteopontin and Collateral Vessel Growth$347,950
R01 · FY2011 · HL · contact PI
Biology, Biomechanics and Atherosclerosis$1,194,109
R01 · FY2010 · HL · contact PI
Role of inflammatory cell RAGE in collateral vessel formation$386,904
P01 · FY2010 · HL · contact PI
Hypertension, Hydrogen Peroxide and Vascular Inflammation$348,750
R01 · FY2010 · HL · contact PI
Osteopontin and Collateral Vessel Growth$347,950
R01 · FY2010 · HL · contact PI
HOWARD UNIVERSITY GENERAL CLINICAL RESEARCH CENTER$1
M01 · FY2010 · RR · contact PI
Biology, Biomechanics and Atherosclerosis$1,199,864
R01 · FY2009 · HL · contact PI
Role of inflammatory cell RAGE in collateral vessel formation$402,212
P01 · FY2009 · HL · contact PI
Osteopontin and Collateral Vessel Growth$361,700
R01 · FY2009 · HL · contact PI
Hypertension, Hydrogen Peroxide and Vascular Inflammation$348,750
R01 · FY2009 · HL · contact PI
Biology, Biomechanics and Atherosclerosis$18,600
R01 · FY2009 · HL · contact PI
HF-ACTION$4,816
M01 · FY2009 · RR · contact PI
Biology, Biomechanics and Atherosclerosis$1,195,510
R01 · FY2008 · HL · contact PI
Hypertension, Hydrogen Peroxide and Vascular Inflammation$335,000
R01 · FY2008 · HL · contact PI
HF-ACTION$7,753
M01 · FY2008 · RR · contact PI
Vascular specific ACE expression and atherosclerosis$483,957
P01 · FY2007 · HL · contact PI
HF-ACTION$20,095
M01 · FY2007 · RR · contact PI
MALT LIQUOR$1,632
M01 · FY2007 · RR · contact PI
IRPG (NOVEL PHENOTYPES)$1,632
M01 · FY2007 · RR · contact PI
Biology, Biomechanics and Atherosclerosis$1,414,561
R01 · FY2006 · HL · contact PI
Vascular Inflammation and Advanced Glycation Endproducts$293,887
R01 · FY2006 · DK · contact PI
Vascular specific ACE expression and atherosclerosis$290,324
P01 · FY2006 · HL · contact PI
IRPG (NOVEL PHENOTYPES)$148,750
M01 · FY2006 · RR · contact PI
MALT LIQUOR$9,296
M01 · FY2006 · RR · contact PI
ONTAD$5,311
M01 · FY2006 · RR · contact PI
HF-ACTION$5,103
M01 · FY2006 · RR · contact PI
Biology, Biomechanics and Atherosclerosis$1,362,895
R01 · FY2005 · HL
Vascular Inflammation and Advanced Glycation Endproducts$300,960
R01 · FY2005 · DK
Vascular specific ACE expression and atherosclerosis$281,868
P01 · FY2005 · HL
Biology, Biomechanics and Atherosclerosis$53,450
R01 · FY2005 · HL
Biology, Biomechanics and Atherosclerosis$1,330,481
R01 · FY2004 · HL
Vascular Inflammation and Advanced Glycation Endproducts$300,960
R01 · FY2004 · DK
Mechanism of Ischemic Preconditioning in Humans$49,977
M01 · FY2004 · RR
Biology, Biomechanics and Atherosclerosis$1,286,201
R01 · FY2003 · HL
Vascular Inflammation and Advanced Glycation Endproducts$298,672
R01 · FY2003 · DK
Biology, Biomechanics and Atherosclerosis$1,313,708
R01 · FY2002 · HL
REGULATION OF OSTEOPONTIN EXPRESSION BY MECHANICAL STRAI$309,000
R01 · FY2002 · HL
INTENSIVE ANTIOXIDANT REGIMEN ON ATHEROSCLEROTIC PLAQUE$0
M01 · FY2002 · RR
INTENSIVE ANTIOXIDANT REGIMEN ON ATHEROSCLEROTIC PLAQUE$0
M01 · FY2002 · RR
REGULATION OF OSTEOPONTIN EXPRESSION BY MECHANICAL STRAI$309,000
R01 · FY2001 · HL
INTENSIVE ANTIOXIDANT REGIMEN ON ATHEROSCLEROTIC PLAQUE$0
M01 · FY2001 · RR
REGULATION OF OSTEOPONTIN EXPRESSION BY MECHANICAL STRAI$309,000
R01 · FY2000 · HL